CAMBRIDGE, Mass., Jan. 5, 2018 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the
36th Annual J.P. Morgan Healthcare Conference on
Thursday, January 11, 2018, at
9:30 a.m. PST (12:30 p.m. EST) in San
Francisco, CA. A live webcast of Infinity's presentation
will be accessible on the Investors/Media section of Infinity's
website at www.infi.com, and will be available for 30 days
following the event.
About Infinity
Infinity is an innovative
biopharmaceutical company dedicated to advancing novel medicines
for people with cancer. Infinity is advancing IPI-549, an oral
immuno-oncology development candidate that selectively inhibits
PI3K-gamma. A Phase 1/1b study in
approximately 200 patients with advanced solid tumors is ongoing.
For more information on Infinity, please refer to Infinity's
website at www.infi.com.
Contact:
Stephanie
Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com
View original
content:http://www.prnewswire.com/news-releases/infinity-to-present-at-36th-annual-jp-morgan-healthcare-conference-300577884.html
SOURCE Infinity Pharmaceuticals, Inc.